GENE EXPRESSION PROFILING IDENTIFIES MCP-3 AS A POTENTIAL MEDIATOR OF FIBROSIS

CP Denton(The Royal Free Hospital), LA Evans, X. Shiwen, Dietmar Abraham(Medical University of Vienna)

UCL Discovery (University College London)

April 1, 2002

Cited by 0

Related Papers

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

|Annals of the Rheumatic Diseases|2003|769

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

|Annals of the Rheumatic Diseases|2010|503

Raf-1-associated Protein Phosphatase 2A as a Positive Regulator of Kinase Activation

|Journal of Biological Chemistry|2000|219

Open-Label Trial of Anti-TNF-α in Dermato- and Polymyositis Treated Concomitantly with Methotrexate

|European Neurology|2008|99

Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test

|Annals of the Rheumatic Diseases|2006|98